ATNM vs SYK · rev $35.0M vs P/E 35, rev $6.59B
Actinium Pharmaceuticals Inc (ATNM) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
ATNM currently screens at market cap $33.9M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the ATNM and SYK stock pages for the full models.
Not investment advice.